Healthcare -
Biotechnology - NASDAQ - US
$ 1.3025
-2.8 %
$ 52.4 M
Market Cap
-1.06
P/E
IKNA - STOCK-BASED COMPENSATION
Stock-based Compensation IKNA - Ikena Oncology, Inc.
7.63 M
LAST VALUE
21.42%
2 YEAR CAGR
89.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR